Lv2
110 积分 2023-09-19 加入
Chemotherapy with or without pembrolizumab followed by maintenance pembrolizumab with or without olaparib as first-line treatment of patients with advanced BRCA non-mutated epithelial ovarian cancer (ENGOT-OV43/GOG-3036/KEYLYNK-001): a randomised, double-blind, placebo-controlled, phase 3 trial
2小时前
待确认
Osimertinib With or Without Chemotherapy in Advanced Non–Small Cell Lung Cancer With EGFR and Concurrent TP53 Mutations
1个月前
已完结
Is There Still Room for Monotherapy in EGFR-Mutated Non-Small Cell Lung Cancer?
1个月前
已完结
Perioperative serplulimab with neoadjuvant chemotherapy versus perioperative chemotherapy in PD-L1-positive gastric cancer (ASTRUM-006): a randomised, double-blind, multicentre, phase 3 study
1个月前
已完结
Novel strategies to overcome the blood–brain barrier in triple-negative breast cancer brain metastases
1个月前
已完结
Clinical and genomic correlates of imatinib response in melanomas with KIT alterations
1个月前
已完结
Targeting claudins in cancer
1个月前
已完结
The DNA damage response and cancer immunotherapy
1个月前
已完结
Activity and safety of atezolizumab plus carboplatin and paclitaxel in patients with advanced or recurrent thymic carcinoma (MARBLE): a multicentre, single-arm, phase 2 trial
1个月前
已完结
Current Management of Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in a Changing Landscape
1个月前
已完结
Methane oxidation in African and European rivers depends on stream size and wetland connectivity
皖公网安备34019202002308
